Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
Diabetes Care - United States
doi 10.2337/dc15-0811
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2015
Authors
Publisher
American Diabetes Association